RxDoctor Payments Data

Barry Palizzi, DO

Family Medicine · Panama City, FLNPI 1104192475

Payments from drug & device makers

$383in general payments, 2019–2025

Across 26 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$87
  • AstraZeneca$76
  • Lilly USA, LLC$39
  • Merck$33
  • Amarin Pharma, Inc.$32
  • AbbVie$25
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$383100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$383 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$87,418
Medicare patients
311
Services billed
1,209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$56,091
JardianceEmpagliflozin33$45,455
OzempicSemaglutide43$40,642
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$33,396
MounjaroTirzepatide24$31,339
TrulicityDulaglutide22$26,293
XareltoRivaroxaban15$18,801
EntrestoSacubitril/Valsartan12$17,096
LinzessLinaclotide13$15,580
Tresiba Flextouch U-100Insulin Degludec12$11,270
Spiriva RespimatTiotropium Bromide14$9,592
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$9,329
MyrbetriqMirabegron11$6,995
BelsomraSuvorexant11$5,477
Omeprazole283$4,760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$39$57,63246 claims
PfizerEliquis$24$56,09149 claims
GSKTrelegy Ellipta, Anoro Ellipta$16$42,72554 claims
Novo NordiskOzempic$87$40,64243 claims
AbbVieLinzess, Synthroid$25$17,33940 claims
NovartisEntresto$19$17,09612 claims
MerckBelsomra$33$5,47711 claims
AstraZenecaSymbicort$76$4,24714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Panama City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →